Ultramicrosize Griseofulvin (CorePharma, LLC)
Welcome to the PulseAid listing for the Ultramicrosize Griseofulvin drug offered from CorePharma, LLC. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | CorePharma, LLC |
| NON-PROPRIETARY NAME: | Ultramicrosize Griseofulvin Tablets |
| SUBSTANCE NAME: | GRISEOFULVIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-09-29 |
| END MARKETING DATE: | 0000-00-00 |
Ultramicrosize Griseofulvin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ultramicrosize Griseofulvin from CorePharma, LLC |
| LABELER NAME: | CorePharma, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/1) |
| START MARKETING DATE: | 2014-09-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64720-295_c4bbdcaf-f7d6-4f94-89f4-776cf643fdbc |
| PRODUCT NDC: | 64720-295 |
| APPLICATION NUMBER: | ANDA204371 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers:
